Literature DB >> 2210989

Generation of complement-derived anaphylatoxins in normal human donor corneas.

B J Mondino1, H L Sumner.   

Abstract

Complement-derived anaphylatoxins (C3a, C4a, and C5a) are potent, stable mediators of acute inflammation. Because human corneas contain functional complement, the authors subjected normal human donor corneas to various forms of immunologic or chemical injury to determine if the complement system could be activated and anaphylatoxins generated. The experimental cornea of each donor pair was injected with lipopolysaccharide (LPS) or immune complexes or injured by application of acid or alkali. The remaining cornea of each donor pair served as a control. After incubation of corneas in tissue culture media for 6 hours and elution in phosphate-buffered saline for 24 hours, C3a, C4a, and C5a were measured in corneal eluates by radioimmunoassay. Compared with control corneas, C3a levels were significantly increased in corneas injected with LPS or immune complexes and in corneas injured with acid or alkali. C4a levels were significantly elevated in corneas injected with immune complexes and in corneas injured with acid or alkali but not in corneas injected with LPS. C5a levels were detectable only in corneas injured with acid or alkali. These results suggest that immunologic reactions in the human cornea may activate the classic or alternative complement pathways and generate anaphylatoxins. Additionally, chemical injuries with acid or alkali generate anaphylatoxins in the cornea. Anaphylatoxins may participate in the acute inflammatory response of the human cornea to chemical or immunologic injury.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210989

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  [Corneal wound healing-Pathophysiology and principles].

Authors:  Tobias Brockmann; Marcus Walckling; Claudia Brockmann; Tho Mas A Fuchsluger; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-06-09       Impact factor: 1.059

Review 3.  The role of complement system in ocular diseases including uveitis and macular degeneration.

Authors:  Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

4.  Peanuts can contribute to anaphylactic shock by activating complement.

Authors:  Marat Khodoun; Richard Strait; Tatyana Orekov; Simon Hogan; Hajime Karasuyama; De'broski R Herbert; Jörg Köhl; Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2009-01-03       Impact factor: 10.793

5.  Dual inhibition of complement component 5 and leukotriene B4 by topical rVA576 in atopic keratoconjunctivis: TRACKER phase 1 clinical trial results.

Authors:  Sara Sánchez-Tabernero; Julia Fajardo-Sanchez; Wynne Weston-Davies; Mohit Parekh; Jaime Kriman; Stephen Kaye; Sajjad Ahmad
Journal:  Orphanet J Rare Dis       Date:  2021-06-11       Impact factor: 4.123

Review 6.  The role of complement in ocular pathology.

Authors:  Nalini S Bora; Purushottam Jha; Puran S Bora
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

7.  Activation of the lectin pathway of complement in experimental human keratitis with Pseudomonas aeruginosa.

Authors:  Michael Osthoff; Karl D Brown; David C M Kong; Mark Daniell; Damon P Eisen
Journal:  Mol Vis       Date:  2014-01-06       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.